(Press-News.org) Gaithersburg, MD—March 28, 2023 – Cartesian Therapeutics, a fully integrated biopharmaceutical company pioneering RNA cell therapy for autoimmune diseases and cancer, today announced the appointment of five internationally recognized experts in autoimmune diseases. Cartesian’s appointments include distinguished physicians and scientists as leaders in clinical trials and medicine.
“Cartesian is proud to have these prestigious, multidisciplinary advisors committed to treating other autoimmune diseases,” said Miloš Miljković, M.D., Chief Medical Officer at Cartesian Therapeutics. “Their perspectives will provide the utmost value to the continued advancement of our clinical pipeline.”
The new Senior Advisors are as follows:
Michael Benatar, MD, PhD is a Professor of Neurology and of Public Health Sciences, Chief of Neuromuscular Division, and Vice Chair for Clinical and Translational Research in the Department of Neurology at the University of Miami School of Medicine. He leads an active clinical and translational research program focused on biomarker and therapy development for ALS. He is also a thought-leader in the MG community, having designed, led, and participated in many clinical trials. He has published over 200 peer-reviewed articles and multiple books.
James F. Howard Jr., MD is Professor of Neurology, Medicine and Allied Health and the prior Chief of the Neuromuscular Disorders section at University of North Carolina, Chapel Hill School of Medicine. A practicing neurologist for over 43 years and an expert on myasthenia gravis and electromyography, Dr. Howard currently directs the Myasthenia Gravis Clinical Trials and Translational Research Unit at UNC.
Susan Manzi, MD, MPH is Professor of Medicine and Chair of the Medicine Institute at Allegheny Health Network, and the Immediate Past Chair of the Board at the Lupus Foundation of America, where she serves as Medical Director. Dr. Manzi is internationally recognized as a pioneer in the investigation of premature cardiovascular disease in systemic lupus erythematosus and in the discovery of biomarkers for lupus diagnosis, monitoring and stratification.
Carolina Barnett-Tapia, MD, PhD is Associate Professor of Neurology and Institute of Health Policy, Management and Evaluation at the University of Toronto. Her research is focused on patient-centered outcomes research in neuromuscular disorders, aiming to incorporate the patients' views and preferences into clinical trials and practice.
Tuan Vu, MD is a Professor of Neurology at the University of South Florida Morsani College of Medicine and the Division Director for Neuromuscular Medicine and EMG. He has authored or co-authored more than 60 peer-reviewed publications on neuromuscular diseases and has been the Principal or Co-Investigator on more than 90 NIH and industry-sponsored grants and clinical trials.
About Cartesian Therapeutics
Cartesian is pioneering RNA cell therapies for autoimmune diseases and cancer. The company’s lead asset, Descartes-08, is a first-in-class, RNA-engineered chimeric antigen receptor T-cell therapy (rCAR-T) in Phase 2b clinical development for patients with generalized myasthenia gravis. Cartesian operates a wholly owned, state-of-the-art cGMP manufacturing facility in Gaithersburg, MD. For more information visit www.cartesiantherapeutics.com.
Media contact: Annette Larkin, annette@renewpr.com, m: 703 772 6427
END
Researchers at the University of Toronto, Indiana University and University of Notre Dame have detected levels of toxic PFAS chemicals—short for per- and polyfluoroalkyl substances—for the first time in Canadian fast-food packaging, specifically water-and-grease repellent paper alternatives to plastic.
Published today in Environmental Science and Technology Letters, the findings suggest that food packaging exposes people directly to PFAS, which have been linked to serious health effects such as increased cancer risk and immune system damage, by contaminating the food they eat. Further, once discarded packaging enters waste streams, PFAS enter the environment, where these ...
HOUSTON – (March 28, 2023) – The road to a net-zero future must be paved with greener concrete, and Rice University scientists know how to make it.
The production of cement, an ingredient in concrete, accounts for roughly 8% of the world’s annual carbon dioxide emissions, making it a significant target of greenhouse gas emissions reduction goals. Toward those efforts, the Rice lab of chemist James Tour used flash Joule heating to remove toxic heavy metals from fly ash, a powdery ...
CHAMPAIGN, Ill. — As new environmental regulations are rolling out to mitigate the industry-retired long-chain chemicals known as PFAS in drinking water, there are concerns regarding a new breed of “forever chemicals” called short-chain PFAS. Research from the University of Illinois Urbana-Champaign is helping shift the focus to include mitigation of the chemicals – which researchers say are just as persistent as, more mobile and harder to remove from the environment than their long-chain counterparts.
A ...
SAN FRANCISCO, CA (March 28, 2023) — In a paper published today in the journal Environmental Research Letters, an international research team composed of scientists affiliated with more than a dozen institutions, including the California Academy of Sciences, propose a first-of-its-kind framework for governments around the world to evaluate their preparedness for—and guide future policies to address—ocean acidification, among the most dire threats to marine ecosystems.
“Ocean acidification is one of climate change’s silent killers,” says Rebecca Albright, PhD, Academy Curator of Invertebrate Zoology and ...
In North America’s hottest, driest desert, climate change is causing the decline of plants once thought nearly immortal and replacing them with shorter shrubs that can take advantage of sporadic rainfall and warmer temperatures.
Many studies have documented how a hotter, drier world is causing a redistribution of plants in temperate mountain regions. A new UC Riverside study documents the unexpected ways plants in part of the Sonoran Desert are doing the same.
“The plants ...
INDIANAPOLIS, March 28, 2023 — Colorful particles of plastic drift along under the surface of most waterways, from headwater streams to the Arctic Ocean. These barely visible microplastics — less than 5 mm wide — are potentially harmful to aquatic animals and plants, as well as humans. So, researchers are devising ways to remove them and to stop them at their source. Today, a team reports a two-stage device made with steel tubes and pulsing sound waves that removes most of the plastic particles from real water samples.
The researchers will present ...
INDIANAPOLIS, March 28, 2023 — The ancient art of origami is well known for transforming sheets of paper and other foldable materials into complex 3D shapes. But now, chemical engineers have extended the centuries-old practice to produce intricate shapes made of glass or other hard materials. Their thoroughly modern method, which can be combined with 3D printing, could have applications ranging from sculpture to catalysis and beyond.
The researchers will present their results today at the spring meeting of the American Chemical Society (ACS). ACS Spring 2023 is a hybrid meeting being held virtually and in-person ...
INDIANAPOLIS, March 28, 2023 — There’s been a recent push in the U.S. to make naloxone — a fast-acting opioid antidote — available without a prescription. This medication has saved lives, but it’s less effective against powerful synthetic opioids, such as fentanyl. In an interesting twist, researchers are now looking to cannabidiol (CBD), a component of marijuana, as a possible alternative to the popular antidote. Today, a team reports compounds based on CBD that reduce fentanyl binding and boost the effects of naloxone.
The researchers will present their results at the spring meeting of the American Chemical Society (ACS). ...
INDIANAPOLIS, March 28, 2023 — Have a cough, sore throat and congestion? Any number of respiratory viruses could be responsible. Conventional tests can identify certain likely culprits by relying on chemical reactions, but some researchers want to swap chemistry for electrical changes sensed by nanomaterials. Today, scientists report using a single-atom-thick nanomaterial to build a device that can simultaneously detect the presence of the viruses that cause COVID-19 and the flu — at much lower levels and much more quickly than conventional tests for either.
The researchers will present their results at the spring meeting ...
Research Highlights:
Weight loss was associated with decreased risk factors for cardiovascular disease and Type 2 diabetes for at least five years — even if some weight was regained, according to a review of research on behavioral weight loss programs.
People who lost weight through an intensive behavioral weight loss program had lower systolic blood pressure levels, total cholesterol-to-good cholesterol ratio and HbA1c levels (a diabetes marker), when compared to people who did not participate in a program or participated in a lower-intensity behavioral program.
Embargoed ...
